These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28850427)

  • 1. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.
    González-Rodríguez S; Poras H; Menéndez L; Lastra A; Ouimet T; Fournié-Zaluski MC; Roques BP; Baamonde A
    Scand J Pain; 2017 Jan; 14():25-38. PubMed ID: 28850427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.
    Bonnard E; Poras H; Nadal X; Maldonado R; Fournié-Zaluski MC; Roques BP
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00116. PubMed ID: 25692029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of osteosarcoma-induced thermal hyperalgesia in mice by the orally active dual enkephalinase inhibitor PL37. Potentiation by gabapentin.
    Menéndez L; Hidalgo A; Meana A; Poras H; Fournié-Zaluski MC; Roques BP; Baamonde A
    Eur J Pharmacol; 2008 Oct; 596(1-3):50-5. PubMed ID: 18692494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain.
    Bonnard E; Poras H; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 2016 Oct; 788():176-182. PubMed ID: 27266667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual enkephalinase inhibitor PL265: a novel topical treatment to alleviate corneal pain and inflammation.
    Reaux-Le Goazigo A; Poras H; Ben-Dhaou C; Ouimet T; Baudouin C; Wurm M; Melik Parsadaniantz S
    Pain; 2019 Feb; 160(2):307-321. PubMed ID: 30412056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive synergism upon the joint use of methadone and Phα1β in a model of cancer-related pain in C57BL/6J mice.
    Ferreira LA; Aoki CT; Santos DC; Rezende MJ; Mendes MP; Moura RA; Delgado MA; Ferreira J; Gomez MV; Castro Junior CJ
    Life Sci; 2021 Aug; 278():119582. PubMed ID: 33961856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
    Curto-Reyes V; Llames S; Hidalgo A; Menéndez L; Baamonde A
    Br J Pharmacol; 2010 Jun; 160(3):561-73. PubMed ID: 20233215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of disulfide dual ENKephalinase inhibitors (DENKIs) activity by a transient N-protection for pain alleviation by oral route.
    Poras H; Bonnard E; Fournié-Zaluski MC; Roques BP
    Eur J Med Chem; 2015 Sep; 102():58-67. PubMed ID: 26241877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management.
    Nieto MM; Wilson J; Walker J; Benavides J; Fournié-Zaluski MC; Roques BP; Noble F
    Neuropharmacology; 2001 Sep; 41(4):496-506. PubMed ID: 11543770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats.
    Kita A; Imano K; Seto Y; Yakuo I; Deguchi T; Nakamura H
    Jpn J Pharmacol; 1997 Dec; 75(4):337-46. PubMed ID: 9469639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
    Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs).
    Raffa RB; Pergolizzi JV; Taylor R; Ossipov MH;
    J Clin Pharm Ther; 2018 Aug; 43(4):443-449. PubMed ID: 29722031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
    Wilkerson JL; Niphakis MJ; Grim TW; Mustafa MA; Abdullah RA; Poklis JL; Dewey WL; Akbarali H; Banks ML; Wise LE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2016 Apr; 357(1):145-56. PubMed ID: 26791602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local loperamide inhibits thermal hyperalgesia but not mechanical allodynia induced by intratibial inoculation of melanoma cells in mice.
    Curto-Reyes V; Juárez L; García-Pérez E; Fresno MF; Hidalgo A; Menéndez L; Baamonde A
    Cell Mol Neurobiol; 2008 Nov; 28(7):981-90. PubMed ID: 18360770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid CB
    Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
    Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone.
    Le Guen S; Mas Nieto M; Canestrelli C; Chen H; Fournié-Zaluski MC; Cupo A; Maldonado R; Roques BP; Noble F
    Pain; 2003 Jul; 104(1-2):139-48. PubMed ID: 12855323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.